Liver disease is a growing health concern in the United States, affecting millions of adults. One of the most common types is called nonalcoholic fatty liver disease (NAFLD). This condition happens ...

Whether you’re taking Ozempic for type 2 diabetes or for weight loss, you’re probably noticing a lot of changes in your body.

A new analysis of obesity guidelines suggests more evidence is needed to develop stronger guidelines for the transition ...

El Bey, a U.S. Marine Corps veteran, and his partner Dena Patterson, have been working to develop El Bey's roughly 11,000 ...

Eli Lilly's experimental obesity drug, eloralintide, helped some patients lose 11.5% of their body weight at 12 weeks in an ...

The AMA passed a resolution to increase access to anti-obesity medications at its annual House of Delegates meeting.The resolution was championed by the Endocrine Society, according to a press release ...

The Danish drugmaker, which is grappling with a share decline and competition from Eli Lilly, unveiled planned trials of an ...

Nonalcoholic fatty liver disease (NAFLD) was linked to elevated liver enzymes in type 2 diabetes mellitus (T2DM) in a recent ...

A new study found that weight-loss medications like Ozempic and Mounjaro are not as effective in a “real-world” setting ...

The UVA Cancer Center is taking a significant step forward in addressing the alarmingly high cancer rates across Virginia and ...

Wegovy maker Novo Nordisk is moving its investigational amycretin asset into late-stage weight loss trials starting early ...

Dietitians agree that diet soda, often painted as a “bad” drink, can be a part of a healthy diet. Low- and no-calorie sweeteners have proven to be safe when consumed in moderation. Diet soda has no ...